Synopsis of recent research by authors named "Hao-Cheng Zheng"
- Hao-Cheng Zheng's research predominantly focuses on identifying noninvasive biomarkers for drug-induced liver injury (DILI), aiming to develop early detection methods that can improve patient outcomes by utilizing salivary metabolites as potential indicators.
- Zheng also explores the therapeutic effects of supramolecular nanoparticles, combining ursodeoxycholic acid and berberine, on ulcerative colitis, contributing to understanding how these compounds can enhance treatment for this chronic inflammatory condition.
- Additionally, his studies investigate the impact of dietary components, such as lamb meat and Basa fish, on pulmonary inflammation and the gut microbiota in asthmatic mice, highlighting the relationship between diet and immune responses in respiratory conditions.
